This is the call to meeting for tomorrow at 2 PM ET. As you know, Kantara has switched to Zoom for the future. Here
is the new link once again for tomorrow at 2 PM ET:
Kantara Initiative is inviting you to a scheduled Zoom meeting.
Topic: Health Identity Assurance WG Time: This is a recurring meeting.
Join Zoom Meeting
Meeting ID: 983 2657 6116 Passcode: 192209
One tap mobile
+13017158592,,98326576116#,,,,*192209# US (Washington DC)
+13126266799,,98326576116#,,,,*192209# US (Chicago)
Dial by your location
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 669 900 9128 US (San Jose)
Meeting ID: 983 2657 6116
Find your local number: https://zoom.us/u/abCvb8Pf7d
Our workgroup is at a crossroad with no obvious path to the future. The Identity ecosystem details we've been discussing for several years and the recommendations for design and implementation,
building upon the original NSTIC guidelines seems to be dependent on government deciding what should be the next steps and how they might be funded.
There has been a lot of technical and administrative progress over the past decade around Id assurance, but still much more to gain acceptance of the
I propose we do some brainstorming tomorrow with "nothing off the table" about next projects, including abundant use cases, let alone the growing debate around vaccine credentials. Apropos, I like
the Greek "omicron" and how many highly paid news anchors say "omnicron" (thinking of my personal history of having studied ancient Greek in college😀)
We have incredible expertise within the current and former active members of this workgroup.
I hope many or most of you can attend tomorrow to share current work and offer new directions.
Unfortunately, Jim Kragh will not be able to attend due to an important conflict tomorrow.
Notice of Confidentiality: The information included and/or attached in this electronic mail transmission may contain confidential or privileged information and is intended for the addressee. Any unauthorized disclosure, reproduction, distribution or the taking
of action in reliance on the contents of the information is prohibited. If you believe that you have received the message in error, please notify the sender by reply transmission and delete the message without copying or disclosing it.